INTRODUCTION
============

Most children with cerebral palsy have impaired gait function due to involuntary muscle spasm and muscle weakness ([@b28-jer-16-1-10]). In particular, according to the International Classification of Functioning, Disability and Health model defined by the World Health Organization, the latest intervention goal is focused on not only physical structure but also daily activities and social participation, in which gait function plays crucial roles ([@b18-jer-16-1-10]; [@b35-jer-16-1-10]). In fact, children with cerebral palsy develop limitations in gait function with regard to both structure and activity ([@b13-jer-16-1-10]). Thus, improving both these aspects is the primary therapeutic goal of treatment among children with cerebral palsy ([@b28-jer-16-1-10]).

In the clinical setting, a wide range of equipment is used as a supplement to conventional therapy in order to improve the gait ability of children with cerebral palsy ([@b33-jer-16-1-10]). The treadmill is one of the equipment that has long been used for rehabilitation of the nervous system ([@b2-jer-16-1-10]; [@b17-jer-16-1-10]; [@b20-jer-16-1-10]). The treadmill effectively improves gait ability through repeated weight loading on an individual's lower limbs ([@b30-jer-16-1-10]). In particular, the positive effects of repetitive task-oriented training involving the treadmill on motor learning among subjects have been reported by multiple systematic reviews ([@b23-jer-16-1-10]; [@b30-jer-16-1-10]; [@b40-jer-16-1-10]).

The latest trend in evidence-based research highlights the importance of qualitative as well as quantitative research ([@b34-jer-16-1-10]). In particular, a systematic review with a meta-analytic technique can be used to make an inference on the combined results of previously published individual studies, using a systematic method ([@b3-jer-16-1-10]). With the increasing need for qualitative research in the field, studies on the effects of treadmills on various types of patients have been conducted, and they have reported positive effects ([@b23-jer-16-1-10]; [@b30-jer-16-1-10]; [@b43-jer-16-1-10]).

However, qualitative research on the effects of treadmill training in children with cerebral palsy remains scarce. Such research requires analysis of multiple aspects of gait function, as interaction of multiple joints is involved. However, previous studies on children with cerebral palsy have many areas that need to be improved ([@b38-jer-16-1-10]). The systematic review by [@b43-jer-16-1-10] did not employ the meta-analytic technique, and thus, it offers no effect size estimated quantitatively. The study by [@b40-jer-16-1-10] examined only two aspects of gait function, namely gait speed and endurance, neglecting other important aspects. As gait function can be measured in various ways and measures are continuously being developed, research needs to incorporate instruments that measure various aspects of gait function. Other systematic reviews and meta-analytic studies had limitations in generalizing their findings because the subjects were children with developmental disorders, including children with Down syndrome and those with cerebral palsy ([@b15-jer-16-1-10]). This indicates the need for a systematic review and meta-analysis on the effects of the treadmill in children with cerebral palsy, improving on previous studies. The purpose of this study was to investigate the effects of the treadmill on specific aspects of gait function (gait endurance, gait speed, limb support time, cadence, and step length) in children with cerebral palsy through a systematic review and meta-analysis.

MATERIALS AND METHODS
=====================

Data sources and searches
-------------------------

This review conducted by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement ([@b24-jer-16-1-10]). Two authors independently conducted searches in August 2019 using electronic data base: Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Central Register of Controlled Trials, Physiotherapy Evidence Database (PEDro), PubMed, and Web of Science. Keywords or Mesh terms (if applicable) used for the search include the following: spastic diplegia(s) or spastic hemiplegia(s) or cerebral palsy(s) or cerebral palsies or little disease or infantile palsies or spastic diplegic or spastic hemiplegic or spastic quadriplegia(s) or spastic, treadmill training or partial body weight treadmill or body weight supported training or treadmill therapy or partial body weight treadmill, gait or walking or walking ability or walking abilities or locomotor training or locomotion or gait function or mobility ([Fig. 1](#f1-jer-16-1-10){ref-type="fig"}).

Data processing
---------------

This systematic review and meta-analysis considered studies that met the following inclusion criteria: (a) enrolled children aged 6--18 years diagnosed with cerebral palsy, (b) compared treadmill training with conventional therapy or a control, (c) measured the outcome with regard to gait speed, limb support time, cadence, and/or step length, and (d) written in English. The exclusion criteria were as follows: (a) insufficient data for estimation of the effect size and (b) demonstration of an immediate effect. Data were coded by individuals skilled in meta-analysis, and the coding was completed after all authors of this study reached an agreement. The author names, published year, study participants, cerebral palsy type, the gross motor function classification scale level, dosage, assessment tools were recorded for data coding.

Data extraction and quality assessment
--------------------------------------

In this study, data were organized using the Patient Intervention Comparator Outcome framework as follows: participants were children diagnosed with cerebral palsy; intervention was treadmill training; comparator was conventional therapy, nontherapy, or other therapy; and outcome was the effect of treadmill training on gait function in children with cerebral palsy. The assessment of gait function included gait speed, gait endurance, limb support time, cadence, and step length. The quality of the included studies was evaluated using the PEDro scale ([@b42-jer-16-1-10]). The scale has 11 items (eligibility criteria, random allocation, concealed allocation, baseline comparability, blinded subjects, blinded therapists, blinded assessors, adequate follow-up, intention to treat, between-group, point estimators), and the total score is interpreted as follows: 9--10: excellent; 6--8: good; 4--6: fair; and \<4: poor. The publication bias of the included studies was assessed using the duval and tweedie's trim and fill method ([@b19-jer-16-1-10]). Since this study was a meta-analysis of published articles, this study was exempt from Institutional Review Board review.

Data synthesis and analysis
---------------------------

Data analysis was performed using Comprehensive meta-analysis software. According to Cohen criteria, the effect size is considered small when ≤0.3, moderate when 0.4--0.7, and large when ≥0.8 ([@b3-jer-16-1-10]).

RESULTS
=======

Characteristics of included trials
----------------------------------

With regard to the characteristics of the included studies ([Table 1](#t1-jer-16-1-10){ref-type="table"}) ([@b5-jer-16-1-10]; [@b7-jer-16-1-10]; [@b8-jer-16-1-10]; [@b11-jer-16-1-10]; [@b12-jer-16-1-10]; [@b14-jer-16-1-10]; [@b16-jer-16-1-10]; [@b41-jer-16-1-10]), Eight studies were considered, and the study by Cherng was divided into two studies according to the switch between the experimental and control groups because of the counterbalance design.

Homogeneity test for selecting model
------------------------------------

As the results of the homogeneity test (Q=21.41, *P*=0.004, *I*^2^=64.95) and visual inspection indicated a high level of homogeneity among the eight included studies, we used the random-effect model to derive estimates. In addition, in subgroup analyses, the estimates for gait speed were obtained using the random-effect model as a high level of heterogeneity was suggested, whereas the estimates for gait endurance, limb support time, cadence, and step length were obtained using the fixed-effect model as a low level of heterogeneity was suggested.

Quality assessment
------------------

On the PEDro scale, the mean score for the included studies was 6.25. Individual item scores are shown in ([Table 2](#t2-jer-16-1-10){ref-type="table"}).

Publication bias assessment
---------------------------

The results of the sensitivity test for bias evaluation using the duval and tweedie's trim and fill method showed that the correlation values and observed values were the same, suggesting low publication bias ([Table 3](#t3-jer-16-1-10){ref-type="table"}).

Combined effect of treadmill training
-------------------------------------

The test regarding the effect of treadmill training on overall gait function yielded a moderate effect size of 0.52 (95% confidence interval \[CI\], 0.19--0.85), which was a statistically significant effect as its confidence interval did not include ([Fig. 2](#f2-jer-16-1-10){ref-type="fig"}).

Gait endurance
--------------

There were three studies that included outcome variables that measured gait endurance. The overall effect size was 0.85 (95% CI, 0.37--1.34), indicating a large effect size ([Fig. 3](#f3-jer-16-1-10){ref-type="fig"}).

Gait speed
----------

There were nine studies that included outcome variables that measured gait speed. The overall effect size was 0.53 (95% CI, 0.15--0.92), indicating a medium effect size ([Fig. 4](#f4-jer-16-1-10){ref-type="fig"}).

Limb support time
-----------------

There were three studies that included outcome variables that measured limb support time. The overall effect size was 0.73 (95% CI, 0.14--1.34), indicating a moderate effect size ([Fig. 5](#f5-jer-16-1-10){ref-type="fig"}).

Cadence
-------

There were four studies that included outcome variables that measured cadence. The overall effect size was 0.14 (95% CI, −0.36 to 0.64), indicating a nonsignificant improvement ([Fig. 6](#f6-jer-16-1-10){ref-type="fig"}).

Step length
-----------

There were three studies that included outcome variables that measured step length. The overall effect size was 0.21 (95% CI, −0.24 to 0.67), indicating a non-significant improvement ([Fig. 7](#f7-jer-16-1-10){ref-type="fig"}).

DISCUSSION
==========

In this review, we investigated the effects of treadmill training on gait function in children with cerebral palsy using meta-analysis. We analyzed eight studies, and the quality assessment yielded a mean score of 6.25 out of 10. The meta-analysis focused on gait function (gait endurance, gait speed, limb support time, cadence, and step length). Limb support time consists of reduced double limb support and increased one limb support time (affected or more affected side). Most children with cerebral palsy have impaired gait speed, gait endurance and asymmetrical movement pattern during gait cycle ([@b5-jer-16-1-10]; [@b13-jer-16-1-10]). Gait endurance, gait speed, limb support time, cadence and step length are important clinical goal for the rehabilitation of children with cerebral palsy ([@b5-jer-16-1-10]; [@b7-jer-16-1-10]; [@b14-jer-16-1-10]). Therefore, in this review we included five variables to estimate gait function. The analysis of overall gait function yielded a moderate effect size. Subgroup analyses yielded a large effect size for gait endurance and a moderate effect size for gait speed and limb support time, whereas there were no significant differences in cadence and step length between the experimental and comparison groups.

Studies regarding the effects of treadmill training on gait function in children with cerebral palsy yielded mixed results ([@b1-jer-16-1-10]; [@b17-jer-16-1-10]; [@b40-jer-16-1-10]). Thus, the overall effect size needed to be estimated using meta-analysis, and the effect size ≥0.5 was considered clinically significant ([@b4-jer-16-1-10]). The overall effect size (*d*=0.52) obtained in the present review suggested that treadmill training is a clinically effective intervention for gait function in children with cerebral palsy. In fact, task-oriented repetitive movement is considered crucial for motor learning in children with cerebral palsy ([@b29-jer-16-1-10]; [@b36-jer-16-1-10]). The reciprocal movement in the lower extremities during treadmill training likely has a positive effect on gait function in children with cerebral palsy.

Subgroup analyses yielded a large effect size for gait endurance in the present review (*d*=0.85). The included studies investigated interventions with relatively long sessions, ranging from 15 min to 30 min. A previous systematic review reported that treadmill training is an effective intervention for increasing cardiopulmonary function and strengthening the lower extremities in children with cerebral palsy ([@b21-jer-16-1-10]; [@b32-jer-16-1-10]; [@b39-jer-16-1-10]). Additionally, a systematic review and meta-analysis on treadmill training reported increased gait distance as an outcome in stroke patients. In particular, low-intensity continuous exercise has been shown to be effective for endurance of lower extremity muscles while avoiding the risk of joint injuries ([@b31-jer-16-1-10]), which was indicated by the large effect size in the present meta-analysis.

The effect of treadmill training was significant with regard to limb support time, with a moderate effect size (*d*=0.73). Children with cerebral palsy have weakness and spasticity of lower extremity ([@b5-jer-16-1-10]; [@b21-jer-16-1-10]). So many children with cerebral palsy have weight bearing related disability ([@b30-jer-16-1-10]). Treadmill training includes partial body weight support or body weight support ([@b23-jer-16-1-10]; [@b25-jer-16-1-10]). In fact, weight bearing training is good for stability, bone mineral density and muscle strengthening of lower extremity ([@b14-jer-16-1-10]; [@b32-jer-16-1-10]; [@b39-jer-16-1-10]). Also, repetitive movement of joint during treadmill training decrease spasticity by dynamic muscle stretching and increase dorsiflexor muscle strengthening ([@b14-jer-16-1-10]). This is likely the reason for the clinically significant effect of treadmill training on limb support time in children with cerebral palsy in the present review.

The effect of treadmill training was significant with regard to gait speed, with a moderate effect size (*d*=0.52). The clinically significant result suggests that repetitive gait training is effective for gait speed. In general, the gait pattern of cerebral palsy children is associated with the use of an inefficient kinetic mechanism due to cocontraction of proximal and distal muscles related to abnormal muscle tone ([@b13-jer-16-1-10]). However, repetitive gait training using a treadmill promotes automatic and rhythmic gait in children with cerebral palsy by activating the central pattern generator of the spinal cord and improves coordination of agonist-antagonist muscles in the lower extremities ([@b9-jer-16-1-10]; [@b12-jer-16-1-10]). In addition, treadmill training is effective for strengthening the leg muscles, and it promotes muscle synergies in children with cerebral palsy, contributing to efficient movement ([@b9-jer-16-1-10]; [@b27-jer-16-1-10]). This is likely the reason for the clinically significant effect of treadmill training on gait speed in children with cerebral palsy in the present review ([@b30-jer-16-1-10]), similar to a previous systematic review and meta- analysis that reported a clinically significant effect of treadmill training on gait speed in stroke patients.

The effects of training on cadence (*d*=0.14) and step length (*d*= 0.21) were small and statistically insignificant, unlike the effects on gait endurance, gait speed and limb support time. According to a previous study, cadence and step length are related to gait pattern and indicate segmental alignment ([@b6-jer-16-1-10]). In individuals with a normal gait pattern, there is a positive correlation between cadence and step length ([@b6-jer-16-1-10]; [@b26-jer-16-1-10]). In fact, improvement of the pathological gait pattern in children with cerebral palsy requires interventions that are more specific than treadmill training, such as adjusting inadequate lever arms, strengthening stabilizer muscles, and controlling overpowered antagonist muscles ([@b10-jer-16-1-10]; [@b37-jer-16-1-10]). Task-oriented training, including treadmill training, is limited with regard to improving motion kinetics by increasing compensatory movement ([@b22-jer-16-1-10]). Therefore, repetitive gait training using the treadmill is likely inadequate for improving the gait pattern in children with cerebral palsy, but is effective for improving gait endurance and speed. However, considering that the effects on cadence and step length were estimated according to three studies and two studies, respectively, in this meta-analysis, caution is warranted when generalizing the results, and the effects need to be analyzed in additional studies in the future.

With regard to the quality of the included studies, the mean PEDro score for the studies was 6.25, indicating good quality, especially considering that the average PEDro score is 5.0 according to the scale developer ([@b42-jer-16-1-10]). With regard to publication bias, the assessment with the duval and tweedie trim and fill method yielded the same correlation and observed values, suggesting low publication bias.

The present review has some limitations. It is difficult to generalize the results owing to the small number of included studies. Also, there are a lot of variables that indicate gait function. But this review not included many variables for gait function. Additionally, the review included relatively old studies, suggesting the need for a review of recent studies, especially those involving recently developed measures of gait function. Finally, future reviews should apply segmentation, with greater specificity, such as segmentation of the intervention period and type and duration of cerebral palsy.

The present systematic review and meta-analysis are regarding the effects of treadmill training on gait function in children with cerebral palsy. The effects of gait endurance, gait speed and limb support time were effective, but have clinically insufficient on cadence and step length. However, the observed significant effect of treadmill training on overall gait function suggests that it is an effective intervention to improve gait function in children with cerebral palsy. Therefore, the results of this review are expected to serve as important therapeutic evidence for the use of treadmill training as a community and clinical intervention in children with cerebral palsy.
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###### 

Study characteristics

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                Group                                     No. of participants Intervention         Sex (male/female)   Age (yr), mean±SD              Cerebral palsy type GMFCS      Dosage                    Outcome
  -------------------- ----------------------------------------- ---------------------------------------- ------------------- ------------------------------ ------------------------------ ------------------------- --------------------------
  [@b8-jer-16-1-10]    Experimental                              7\                                       5/2                 8.5±2.6                        Athetoid quadriplegia 4\       30 min 2 day×6 wk         10 MWT\
                                                                 PBWSTT+usual physical activity program                                                      Spastic diplegia 1\                                      10-MWT
                                                                                                                                                             Spastic quadriplegia 2\                                  
                                                                                                                                                             GMFCS level 3(2), 4(5)                                   

  Control              7\                                        5/2                                      9.5±2.9             Athetoid quadriplegia 4\                                                                
                       Usual physical activity program                                                                        Spastic diplegia 1\                                                                     
                                                                                                                              Spastic quadriplegia 2\                                                                 
                                                                                                                              GMFCS level 3(2), 4(5)                                                                  

                                                                                                                                                                                                                      

  [@b5-jer-16-1-10]    Experimental                              4\                                       2/2                 4.5±2                          Spastic diplegia 4\            20 min 2 or 3 day×12 wk   Gait speed\
                                                                 TBWS+regular therapeutic treatment                                                          GMFCS level 2(1), 3(3)                                   Cadence\
                                                                                                                                                                                                                      Gait stride length\
                                                                                                                                                                                                                      Gait double limb support

  Control              4\                                        4/0                                      4.5±2               Spastic diplegia 4\                                                                     
                       Regular therapeutic treatment                                                                          GMFCS level 2(1), 3(3)                                                                  

                                                                                                                                                                                                                      

  [@b41-jer-16-1-10]   Experimental                              12\                                      6/6                 10.3±3.1                       Not report\                    30 min 2 day×9 wk         10 MWT\
                                                                 PBWSTT+usual physiotherapy                                                                  GMFCS level 3(5), 4(7)                                   10-MWT\
                                                                                                                                                                                                                      SFA

  Control              14\                                       9/5                                      11.2±4.1            Not report\                                                                             
                       Over ground walking+usual physiotherapy                                                                GMFCS level 3(3), 4(11)                                                                 

                                                                                                                                                                                                                      

  [@b11-jer-16-1-10]   Experimental                              15\                                      10/5                11.9±1.1                       Spastic hemiplegia 15\         15 min 3 day×12 wk        Gait speed\
                                                                 TGT+traditional physical therapy                                                            GMFCS level 2(15)                                        Step length\
                                                                                                                                                                                                                      Ambulation index\
                                                                                                                                                                                                                      Time of support

  Control              15\                                       6/9                                      11.2±1.1            Spastic hemiplegia 15\                                                                  
                       Traditional physical therapy                                                                           GMFCS level 2(15)                                                                       

                                                                                                                                                                                                                      

  [@b16-jer-16-1-10]   Experimental                              14\                                      7/7                 9.7±2.2                        Spastic diplegia 8\            30 min 5 day×12 wk        Spasticity\
                                                                 SSTTEP                                                                                      Spastic quadriplegia 6\                                  Strength\
                                                                                                                                                             GMFCS level 2(1), 3(9), 4(4)                             Motor control\
                                                                                                                                                                                                                      GMFM\
                                                                                                                                                                                                                      Cadence\
                                                                                                                                                                                                                      Step length\
                                                                                                                                                                                                                      PODCI

  Control              12\                                       7/5                                      9.6±2.4             Spastic diplegia 4\                                                                     
                       Strengthening                                                                                          Spastic quadriplegia 6\                                                                 
                                                                                                                              Spastic triplegia 2\                                                                    
                                                                                                                              GMFCS level 2(1), 3(6), 5(5)                                                            

                                                                                                                                                                                                                      

  [@b7-jer-16-1-10]    Experimental                              11\                                      6/5                 15.9±2                         Spastic diplegia 9\            30 min 3 day×12 wk        GMFM\
                                                                 TGT                                                                                         Spastic tetraplegia 2\                                   10-MWT\
                                                                                                                                                             GMFCS level 1(3), 2(4), 3(4)                             MAS

  Control              11\                                       7/4                                      16±1.6              Spastic diplegia 10\                                                                    
                       Conventional physiotherapy                                                                             Spastic tetraplegia 1\                                                                  
                                                                                                                              GMFCS level 1(2), 2(5), 3(4)                                                            

                                                                                                                                                                                                                      

  [@b12-jer-16-1-10]   Experimental                              16\                                      6/10                6.8±2.6                        Not report\                    30 min 2 day×7 wk         6 MWT\
                                                                 TGT                                                                                         GMFCS level 1(5), 2(8), 3(3)                             TUG\
                                                                                                                                                                                                                      BBS

  Control              17\                                       9/8                                      6.0±1.5             Not report\                                                                             
                       Over ground walking                                                                                    GMFCS level 1(8), 2(7), 3(2)                                                            

                                                                                                                                                                                                                      

  [@b14-jer-16-1-10]   Experimental                              10\                                      Not report          12±4                           Spastic diplegia 8\            23 min 3 day×9 wk         Gait speed\
                                                                 BDTT                                                                                        Spastic hemiplegia 2\                                    Cadence\
                                                                                                                                                             GMFCS level 1(4), 2(6)                                   Step length\
                                                                                                                                                                                                                      GMFM\
                                                                                                                                                                                                                      TUG\
                                                                                                                                                                                                                      MAS\
                                                                                                                                                                                                                      Ankle joint\
                                                                                                                                                                                                                      Muscle-tendon\
                                                                                                                                                                                                                      Total strain\
                                                                                                                                                                                                                      Stiffness

  Control              10\                                       Not report                               12±4                Spastic diplegia 8\                                                                     
                       Stretching                                                                                             Spastic hemiplegia 2\                                                                   
                                                                                                                              GMFCS level 1(4), 2(6)                                                                  
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SD, standard deviation; GMFCS, gross motor function classification scale; PBWSTT, partial body weight supported treadmill training; 10MWT, 10-min walking test; 10-MWT, 10-m walking test; TBWS, treadmill training with body weight support; SSTTEP, supported speed treadmill training exercise program; GMFM, gross motor function measure; PODCI, pediatric outcomes data collection instrument; TGT, treadmill gait training; 6 MWT, 6-min walking test; BBS, Berg balance scale; PBWSTT, partial body weight supported treadmill training; SFA, school function assessment travel scale; TUG, Timed Up and Go test; MAS, modified Ashworth scale; BDTT, backward downhill treadmill training.

###### 

Quality assessment (PEDro scale)

  Study                Item   Total                                       
  -------------------- ------ ------- --- --- --- --- --- --- --- --- --- ---
  [@b8-jer-16-1-10]    √      1       1   1   1   0   0   1   1   1   1   8
  [@b5-jer-16-1-10]    √      0       1   0   1   0   0   1   1   0   1   5
  [@b41-jer-16-1-10]   √      1       1   1   0   0   0   0   1   1   1   6
  [@b11-jer-16-1-10]   √      1       1   1   1   0   0   1   1   1   1   8
  [@b16-jer-16-1-10]   √      1       1   0   1   0   0   0   0   0   1   4
  [@b7-jer-16-1-10]    √      1       1   1   1   0   0   1   1   1   1   8
  [@b12-jer-16-1-10]   √      0       1   1   1   0   0   1   1   1   1   7
  [@b14-jer-16-1-10]   √      1       0   1   0   0   0   0   0   1   1   4

PEDro, physiotherapy evidence database; 1, eligibility criteria; 2, random allocation; 3, concealed allocation; 4, baseline comparability; 5, blinded subjects; 6, blinded therapists; 7, blinded assessors; 8, adequate follow-up; 9, intention to treat; 10, between group; 11, point estimators.

###### 

Publication bias

  Value      Study   Point estimate   95% CI       Q-value
  ---------- ------- ---------------- ------------ ---------
  Observed   \-      0.52             0.19--0.85   22.82
  Adjusted   0       0.52             0.19--0.85   22.82

CI, confidence interval.
